다우존스 지수

브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.

등록

홈
인베스팅
주식
영국
LSE
Basilea Pharmaceutica Ag (0QNA)
Basilea Pharmaceutica Ag (0QNA) 뉴스

0QNA

Basilea Pharmaceutica (0QNA)

Basilea Pharmaceutica Ag

일자:

규정 관련뉴스

텍스트 검색:

정렬 기준:

규정 외 뉴스

검색 관련기사 보기:LSE:0QNA

1

일자	시간	출처	헤드라인	심볼	기업
2024/05/16	14:15	UK Regulatory	Strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	LSE:0QNA	Basilea Pharmaceutica Ag
2024/05/16	14:15	UK Regulatory	Starke Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus	LSE:0QNA	Basilea Pharmaceutica Ag
2024/05/03	14:15	UK Regulatory	Basilea reports presentation of new data for ceftobiprole (Zevtera®) at ESCMID Global 2024	LSE:0QNA	Basilea Pharmaceutica Ag
2024/05/03	14:15	UK Regulatory	Basilea berichtet über Präsentation neuer Daten zu Ceftobiprol (Zevtera®) auf dem Fachkongress ESCMID Global 2024	LSE:0QNA	Basilea Pharmaceutica Ag
2024/04/25	01:00	UK Regulatory	Basilea-Aktionäre genehmigen an der Generalversammlung alle Anträge des Verwaltungsrats	LSE:0QNA	Basilea Pharmaceutica Ag
2024/04/25	01:00	UK Regulatory	Basilea shareholders approve all proposals of the board of directors at the annual general meeting	LSE:0QNA	Basilea Pharmaceutica Ag
2024/04/09	14:15	UK Regulatory	Basilea awarded CARB-X grant to develop recently acquired novel class of antibiotics	LSE:0QNA	Basilea Pharmaceutica Ag
2024/04/09	14:15	UK Regulatory	Basilea erhält CARB-X-Förderung für die Entwicklung einer kürzlich erworbenen neuen Antibiotika-Wirkstoffklasse	LSE:0QNA	Basilea Pharmaceutica Ag
2024/04/04	14:15	UK Regulatory	Basilea gibt Erhalt der US-FDA-Zulassung für Antibiotikum ZEVTERA® (Ceftobiprol-Medocaril) für drei Indikationen bekannt	LSE:0QNA	Basilea Pharmaceutica Ag
2024/04/04	14:15	UK Regulatory	Basilea announces US FDA approval of antibiotic ZEVTERA® (ceftobiprole medocaril) for three indications	LSE:0QNA	Basilea Pharmaceutica Ag
2024/03/11	15:15	UK Regulatory	Continued strong Cresemba® (isavuconazole) sales performance in Asia Pacific and China triggers milestone payment to Basilea	LSE:0QNA	Basilea Pharmaceutica Ag
2024/03/11	15:15	UK Regulatory	Anhaltend gute Cresemba® (Isavuconazol)-Umsätze in der Region Asien-Pazifik und China lösen Meilensteinzahlung an Basilea aus	LSE:0QNA	Basilea Pharmaceutica Ag
2024/02/13	15:15	UK Regulatory	Basilea reports strong 2023 full-year results with profitability significantly above guidance, whilst substantially expanding the R&D portfolio	LSE:0QNA	Basilea Pharmaceutica Ag
2024/02/13	15:15	UK Regulatory	Basilea meldet starkes Gesamtjahr 2023 mit einer über der Guidance liegenden Profitabilität trotz substanziell erweitertem F&E-Portfolio	LSE:0QNA	Basilea Pharmaceutica Ag

검색 관련기사 보기:LSE:0QNA

1

Terra Luna Classic

Tisdale Clean Energy

Nederlandse Gasunie NV 0...

SilverBox Engaged Merger...

Telo Genomics (QB)

Sizzle Acquisition

Oat Tf 4% Ap60 Eur

Janus Henderson Short Du...

Recyclico Battery Materi... (QB)

WisdomTree Commodity Sec...

Delayed Upgrade Clock

도움 및 지원받기: kr-support@advfn.com

ADVFN 서비스 이용은 ADVFN의 이용약관에 동의하는 것입니다 이용약관